Aprotinin, an inhibitor of the enzymatic activity of kallikrein in vit
ro, has been used to study the possible contributions of the kallikrei
n-kinin systems to physiological and pathological conditions. Pharmaco
kinetic studies indicate that aprotinin is concentrated in the kidney;
however, there is little information with regard to its cellular dist
ribution. The purpose of the present work was to study the cellular di
stribution of aprotinin, which would be valuable for a better understa
nding of its intrarenal effects. Sprague-Dawley rats (200-250 g, n = 3
6) received aprotinin (50 000 KIU/rat) and were killed at different in
tervals after its administration. The kidneys were examined histologic
ally and the cellular distribution of aprotinin was studied by immunoh
istochemistry. Aprotinin was localized at 30 min concentrated within v
esicles in the apical border of the proximal tubule cells. Later (2 h)
it was observed distributed over the cytoplasm, where it remained for
the 24 h studied. Aprotinin was also detected in connecting tubule ce
lls colocalized with kallikrein, and in the basal portion of collectin
g tubule cells. No evidence of endogenous aprotinin was observed. The
binding of aprotinin to the connecting tubule cells and collecting duc
ts offers a partial explanation of its renal effects.